Drug intelligence / Profile preview

Bacitracin + Lidocaine + Polymyxin B

Development stage
Unknown
Lead developer
Johnson & Johnson Consumer Inc. (J&JCI)
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

The combination of polymyxin B, bacitracin, and lidocaine is a topical antibiotic medication with pain relief properties. It's commonly used to prevent infections in minor skin injuries such as cuts, scrapes, and burns[1][2]. This medication is available over-the-counter in the United States[7]. ## Composition and Mechanism This combination contains three antibiotics (polymyxin B, bacitracin, and neomycin) plus lidocaine, which provides pain relief[1][3]. Each component has a specific function: - **Bacitracin**: Prevents formation of bacterial protective covering essential for bacterial survival[5] - **Lidocaine**: Acts as a local anesthetic by blocking pain signals from nerves to brain, decreasing pain sensation and skin irritation[5] - **Polymyxin B**: Kills bacteria by destroying the bacterial cell membrane[5]

Brand names
Neosporin Plus Maximum StrengthFirst Aid Triple Antibiotic with Pain RelieverProCoMycinSx1 Medicated Post-Operative SystemSx-1 Medicated Post-Operative SystemSx 1 Medicated Post-Operative System
02

Targets

LPS (Lipopolysaccharide)UppP (Undecaprenyl-diphosphate phosphatase)NaV alpha (Voltage-gated sodium channel alpha subunit family)

Beyond the preview

Go deeper on Bacitracin + Lidocaine + Polymyxin B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacitracin + Lidocaine + Polymyxin B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call